Literature DB >> 24247291

A comparison of results of the US food and drug administration's mini-sentinel program with randomized clinical trials: the case of gastrointestinal tract bleeding with dabigatran.

Ilke Sipahi1, Seden Celik2, Nurdan Tozun3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24247291     DOI： 10.1001/jamainternmed.2013.12217

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  12 in total

1.  Severe haematuria of lower urinary tract origin with low dose dabigatran use in three Indian elderly patients: unresolved issues in the safety of novel oral anticoagulants.

Authors:  Upinder Kaur; Sankha Shubhra Chakrabarti; Sukdev Manna; Indrajeet Singh Gambhir
Journal:  Ther Adv Drug Saf       Date:  2017-11-23

2.  Capsule commentary on Ott et al., do statins impair cognition? A systematic review and meta-analysis of randomized controlled trials.

Authors:  Huseyin Naci
Journal:  J Gen Intern Med       Date:  2015-03       Impact factor: 5.128

Review 3.  Bypass grafting versus percutaneous intervention in multivessel coronary disease: the current state.

Authors:  Ilke Sipahi
Journal:  Curr Cardiol Rep       Date:  2015-02       Impact factor: 2.931

4.  Cardiac glycosides decrease influenza virus replication by inhibiting cell protein translational machinery.

Authors:  Luciano Amarelle; Jeremy Katzen; Masahiko Shigemura; Lynn C Welch; Héctor Cajigas; Christin Peteranderl; Diego Celli; Susanne Herold; Emilia Lecuona; Jacob I Sznajder
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-03-20       Impact factor: 5.464

Review 5.  FDA Policy and Cardiovascular Medicine.

Authors:  Joseph S Ross; Aaron S Kesselheim
Journal:  Circulation       Date:  2015-09-22       Impact factor: 29.690

Review 6.  Enhanced elimination of dabigatran through extracorporeal methods.

Authors:  Nadia I Awad; Luigi Brunetti; David N Juurlink
Journal:  J Med Toxicol       Date:  2015-03

7.  Gastrointestinal bleeding. Gastrointestinal bleeding risk is increased by novel anticoagulants.

Authors:  Don C Rockey
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-01-20       Impact factor: 46.802

8.  Association of Novel Oral Antithrombotics With the Risk of Intraocular Bleeding.

Authors:  Katherine E Uyhazi; Todd Miano; Wei Pan; Brian L VanderBeek
Journal:  JAMA Ophthalmol       Date:  2018-02-01       Impact factor: 7.389

Review 9.  Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment.

Authors:  Allison E Burnett; Charles E Mahan; Sara R Vazquez; Lynn B Oertel; David A Garcia; Jack Ansell
Journal:  J Thromb Thrombolysis       Date:  2016-01       Impact factor: 2.300

10.  Adverse drug event rates in pediatric pulmonary hypertension: a comparison of real-world data sources.

Authors:  Alon Geva; Steven H Abman; Shannon F Manzi; Dunbar D Ivy; Mary P Mullen; John Griffin; Chen Lin; Guergana K Savova; Kenneth D Mandl
Journal:  J Am Med Inform Assoc       Date:  2020-02-01       Impact factor: 4.497
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.